This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Global $10.5 Billion Paper Diagnostics Market Analysis by Device Type, Application, Product, End-use, and Region - Forecast to 2025 - ResearchAndMarkets.com

March 6, 2019

DUBLIN--(BUSINESS WIRE)--Mar 6, 2019--The “Paper Diagnostics Market Analysis Report By Device Type (Diagnostics, Monitoring), By Application, By Product (Lateral Flow Assays, Paper Based Microfluidics), By End Use, and Segment Forecasts, 2018 - 2025” report has been added to ResearchAndMarkets.com’s offering.

The global paper diagnostics market size is estimated to reach USD 10.5 billion by 2025, rising at a CAGR of 8% during the forecast period.

Increasing prevalence of diseases such as cancer, autoimmune diseases, and inflammatory diseases is one of the key factors expected to fuel the demand for novel and rapid diagnostics techniques, thereby driving the market during the forecast period.

For instance, as per the American Cancer Society, in 2018, around 1.7 million new cancer cases are likely to be diagnosed and 609,640 individuals are poised to die due to cancer. The number of cancer cases is projected to rise by around 70.0% over the next two decades. This trend is anticipated to help the market gain momentum during the forecast period.

Rising R&D investments, technological advancements, and new product launches are the key growth strategies incorporated by companies to cater to rising needs. ARKRAY Inc.; Acon Laboratories, Inc. Abbott; Bio-Rad Laboratories; Siemens healthcare; Abcam Plc; and Abingdon Health are some of the players focusing on new product development by rising R&D investments.

For instance, in March 2017, ARKRAY Inc. launched saliva testing system, capable of measuring cariogenic bacteria, acidity & buffer capacity, occult blood, leukocyte & proteins, and ammonia from saliva. Moreover, in May 2017, ACON Laboratories, Inc. received U.S. FDA approval for its Mission Urine Reagent Strips for detection of Microalbumin and Creatinine.

Further key findings from the report suggest:

  • Introduction of technologically advanced paper based diagnostic products, which offer sensitive and rapid results, is estimated to boost market growth over the forecast period
  • Development of paper-based ELISA for detection of autoimmune antibodies in body fluid is expected to bolster the demand for technologically advanced & upgraded lateral flow assays over the forecast period
  • Lateral flow assays held a significant share in the market in 2017, owing to wide application in disease diagnostics and associated advantages such as robust & rapid results, sensitivity, ease of use, and cost efficiency
  • Paper based diagnostic devices are widely used as point-of-care diagnostics. Increasing inclination towards these devices can be attributed to advent of wax patterning technology, facilitating greater flexibility and adaptability
  • In terms of application, the clinical diagnostics segment is likely to witness lucrative growth during the same period. Rising awareness regarding their benefits such as improved control and rapid results and growth prospects in area of nanomaterial & biomolecules are contributing to the growth of the segment
  • In 2017, North America was the most prominent regional market, owing to surging demand for self-testing devices coupled with well-established healthcare infrastructure
  • Market leaders are involved in R&D activities to develop accurate, cost efficient, and sensitive paper based microfluidics. Focus on mergers and acquisitions, consistent system upgradation through R&D investments and fund raising are some of the key strategies adopted by players.

Topics Covered

Chapter 1 Report Scope

1.1 Segment Market Scope

1.2 Regional Scope

1.3 Estimates & Forecast Timeline

Chapter 2 Research Methodology

2.1 Model Details

2.1.1 Regression And Variable Analysis

2.1.2 Total Addressable Market (TAM)

2.2 Information Procurement

2.3 List Of Primary Sources

2.3.1 Purchased Database:

2.3.2 Internal database

2.4 Primary Interview Breakup

2.4.1 Data For Primary Interviews, By Sources

2.4.2 Data For Primary Interviews, By Region

2.5 List Of Secondary Sources

Chapter 3 Report Objectives

3.1 Objectives

Chapter 4 Executive Summary

4.1 Market Summary

Chapter 5 Paper diagnostics market: Industry Outlook

5.1 Market Variable Analysis

5.2 Market Driver Analysis

5.2.1 Rising Incidence Of Infectious Diseases And Cancer

5.2.2 Rising Demand For Point-Of-Care And In-Vitro Diagnostics

5.2.3 Introduction Of Technologically Advanced Paper Diagnostics Technologies

5.3 Market Restraints Analysis

5.3.1 Limited Quantitative Application

5.3.2 Lack Of Specific Regulatory Framework

5.4 Business Environment Analysis Tools

5.4.1 Paper Diagnostics Market - Swot Analysis, By Factor (Political & Legal, Economic And Technological)

5.4.2 Porter’s Five Forces Analysis

Chapter 6 Competitive & Vendor Landscape

6.1 Market Participation Categorization

Chapter 7 Paper Diagnostics Market: Product Analysis

7.1 Product Business Analysis

7.2 Dipsticks

7.3 Lateral Flow Assays

7.4 Paper Based Microfluidics Devices

Chapter 8 Paper Diagnostics Market: Devices Type Analysis

8.1 Product Business Analysis

8.2 Diagnostic devices

8.3 Monitoring Devices

Chapter 9 Paper Diagnostics Market: Application Analysis

9.1 Product Business Analysis

9.2 Clinical diagnostics

9.3 Food Quality Testing

9.4 Environmental Monitoring

Chapter 10 Paper Diagnostics Market: End-use Analysis

10.1 Product Business Analysis

10.2 Home healthcare

10.3 Assisted Living Healthcare Facilities

10.4 Hospitals And Clinics

10.5 Others

Chapter 11 Paper Diagnostics Market: Regional Analysis By Product, By Devices Type, By Application, By End-use

11.1 North America

11.2 Europe

11.3 Asia Pacific

11.4 Latin America

11.5 MEA

Chapter 12 Company Profiles

12.1 Key Company Profiled

12.1.1 Arkray Inc.

12.1.2 Acon Laboratories Inc.

12.1.3 Abbott (Alere Inc.)

12.1.4 Bio-Rad Laboratories Inc.

12.1.5 GVS S.p.A.

12.1.6 Siemens Healthcare GmbH

12.1.7 Diagnostics For All Inc.

12.1.8 Ffei Life Science (Biognostix)

12.1.9 Navigene

12.1.10 Micro Essential Laboratory Inc.

12.1.11 Kenosha Tapes

For more information about this report visit https://www.researchandmarkets.com/research/992sgw/global_10_5?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190306005335/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 03/06/2019 06:01 AM/DISC: 03/06/2019 06:01 AM